BICYCLE THERAPEUTICS PLC (BCYC): Submission of Matters to a Vote of Security Holders
BICYCLE THERAPEUTICS PLC (BCYC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001761612 X0 00-0000000 true 0001761612 2026-06-17 2026-06-17 0001761612 us-gaap:CommonStockMember 2026-06-17 2026-06-17 0001761612 bcyc:AmericanDepositarySharesMember 2026-06-17 2026-06-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCH
How this was made
The 30-second read
Why it matters
The disclosed items were director re-elections, an advisory say-on-pay proposal, and ratification/re-appointment of PricewaterhouseCoopers LLP as auditors, all described as duly passed.
Market read
This is a routine governance disclosure with no new clinical, financial, or regulatory information; trading impact should be limited.
What to watch
The document references the April 22, 2026 definitive proxy statement for detailed proposals; any real signal would likely be in that proxy, not in the vote tally itself.
Background
The filing is an SEC Form 8-K under Item 5.07 reporting matters submitted to a vote of security holders at Bicycle Therapeutics’ June 17, 2026 AGM.
Ticker impact
Bicycle Therapeutics reported AGM voting results on June 17, 2026, including director re-elections and auditor ratification under Item 5.07.
Limited near-term impact; any reaction is likely muted and short-lived.
The 8-K is a standard Item 5.07 disclosure of votes passed, with no changes to guidance, trials, financing, or enforcement actions.
Market effects
No sector read-across; governance-only filing for a biotech issuer.
Minimal; US-listed ADS governance disclosure.
Minimal; UK-incorporated company’s routine AGM results.
Counterpoint
If investors were expecting a contested vote or auditor change, the clear “passed” outcomes could reduce uncertainty, but the filing still lacks new fundamentals.
Key entities
- issuerBicycle Therapeutics plc
Company reporting AGM voting results on June 17, 2026 via Item 5.07 of Form 8-K.
- auditorPricewaterhouseCoopers LLP
Independent registered public accounting firm and UK statutory auditor ratified/re-appointed for 2026.
- directorFelix Baker
Re-elected as a director (Proposal 1).
- directorHervé Hoppenot
Re-elected as a director (Proposal 2).